Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|HER2 sensitized T-cells||HER2 (ERBB2) Antibody 53||HER2 sensitized T-cells are autologous T-cells that have been sensitized to HER2 antigen, potentially resulting in increased immune response against HER2-expressing tumor cells upon transplantation (PMID: 24162107, PMID: 20068073).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT02442297||Phase I||HER2 sensitized T-cells||T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS Tumors (iCAR)||Recruiting||USA||0|
|NCT00902044||Phase I||Fludarabine Cyclophosphamide HER2 sensitized T-cells||Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma||Active, not recruiting||USA||0|